• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    alpha -[3(R)-Substituted amino-4(R)-substituted alkoxy-2-oxo-azetidin-1-yl]- alpha -isopropenylacetate (Ia) and alpha -[3(R)-substituted amino-4(R)-substituted alkoxy-2-oxo-azetidin-1-yl]- alpha -isopropylideneacetate (Ib) prepared from (1R,5S)- alpha -(3-substituted-7-oxo-4-oxa-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)- alpha -isopropenylacetate or (1R,5S)- alpha -(3-substituted-7-oxo-4-oxa-2,6-diazabicyclo-[3.2.0]hept-2-en-6-yl)- alpha -isopropylideneacetate with a primary alcohol in the presence of an acid. The products are useful intermediates for preparing oxadethiacephalosporins.
    公开号:SU869558A3
    申请号:SU782577000
    申请日:1978-02-08
    公开日:1981-09-30
    发明作者:Юэо Соичиро；Есиока Мицуру；Цудзи Терудзи；Киккава Икуо；Нагата Ватару
    申请人:Сионоги Энд Ко., Лтд (Фирма)；
    IPC主号:
    专利说明:

    (54) METHOD FOR PRODUCING AZETIDINONONE PRODUCTION
    The invention relates to a process for the preparation of azetidinone derivatives using 1x as intermediates in the synthesis of biologically active compounds. A number of azetid non compounds are known, having 1c: 1x different structure and Cl shape. The purpose of the invention is to obtain ny compounds that are intermediate products for the preparation of biologically active compounds. Azetidinone derivatives are represented by the formulas OCHjRg HIGH s-RjCOHH OCHiRz r c where R - phenyl, phenylthio or phenoxymethyl; 9. - vinyl, these NIL, haloethynyl or a residue of formula-t-C.j-2,. . . where Y is oxygen, methylene or methoxycarbonylmethylene, Z is eschetoxy or 1-methyltetra13ol-5-yl-thio; R. - phenylmethoxy, diphenylmethoxy or tert-butyloxy. Preferred compounds are i- (2-oxo-azetidin-1-yl) -o1-isopropenyl acetate (1a) io, - (2-oxo-azetidin-1-yl) -A-isopropylidene acetate (1b), which both have substituted amide a group (R CONH-) in position 3 in the R configuration and a substituted alkoxy group (RjCHf O-) in position 4 in the R configuration. In addition, any group in the aMtra group in position 6 or 7 of natural or synthetic penicillins or cephalosporins can be represented as the R, CO group of compounds 1a and 16, and any acyl side chain used in the synthesis of antibiotics is also applicable in the proposed method. The group R varies widely.
    when this does not adversely affect the course of the reaction, since the removal or introduction of a group at any stage of the synthesis is not necessary to obtain the final product 1-oxalethiacephalosporins.

     R
    %
    //
    N-CH-C
    sn cor
    3
    On
    /.CN
    N 0 /
    / lo H
    where R. has the above values, in the presence of boron trifluoride or trifluoromethanesulfonic acid at 040 s, followed by, if necessary, isomerization of the compound with total Ha to a compound of general formula i-b in methylene chloride in the presence of triethylamine for 1 minute to 5 hours.
    According to a known method, the oxazoline nitrogen and the oxazolinic acid hydrogen are in the B-position of the azetidine ring, i.e. in the opposite position to that found in the starting compounds of general formula Pa and if b, and using methanol instead of specially substituted alcohols of general formula III in the proposed method. For this reason, 6-hydrohydrogen is formed selectively instead of 6 6-hydrogen in a known method. Hydrogen at position Gd. is integral
    IV
    where R and Rn are specified,
    value.
    Another starting compound of the formula 1 Gb is easily obtained by reacting a double bond isomer and an organic base, for example, an alkylamine, aralkylamine or an inorganic base, for example, alkali metal hydroxides, at 0-70 ° C in an inert solvent.
    This goal is achieved by the fact that in the method of obtaining derivatives of azazidine of the general formulas Ta or 1b a compound of the general formulas il a. or MB is interacting with
    RjCHjOH
    alcohol of general formula III
    / OCHiR
    CORj
    Iq
    OR
    Riconh
    OCHiR
    r
    N-CSC- S co.
    G6G
    part of an effective 1-oxasethiacephalsporine. In addition, the structure of compound 16 is convenient for cyclization with the formation of 1-oxadethiacephalosporins
    The reaction can be carried out at 0-40 ° C, preferably at room temperature, in the presence or absence of a solvent, methylene chloride.
    Upon completion of the reaction, the resulting compound can be isolated and purified using solid methods: extraction, washing with water, drying, concentration, chromatographic separation, etc.
    The compound of formula II is obtained by heating b-epi-penicillin-1-oxide of general formula IV at 70-130 °, preferably in the presence of a desulfurizing agent, for example triarylphosphine, trialkylphosphine and trial kil phosphite a,
    Ry
    X
    to
    CH,
    , L N-CH-C
    at /
    X
    CH,
    COR
    i
    ia
    权利要求:
    Claims (1)
    [1]
    In addition, compound 1a obtained by the proposed method is also converted into compound 1b in a similar way. Thus, compound Ha is treated with an organic, e.g. alkylamine or aralkylamine, or inorganic, e.g. an alkali metal hydroxide or carbonate, bases in an inert solvent. At O-70®C, the reaction is completed within 1 minute to 5 hours. The solvent indicated is spi and other organic solvents suitable for reacting a Na or MB compound with an I1 compound. Compound 16 is used to prepare 1-oxadethiacephalosporins. Namely, Compound 1b is hydrated, oxidized with side chain cleavage at position 1 of the azetidine ring, then reduced, halogenated at the hydroxy group of the substituent at position 1, and reacted with triphenylphosphine to form the Wittig compound. The Wittig compound thus obtained is cycled to form the desired 1-oxalethiacephalosporin. The proposed method allows 1-oxadethiacephalosporins to be obtained with greater selectivity and high yield. Example 1. Difa NILE methyl-el-4 (K) -propargyloxy-3 (K) -phenylacetamido-2-oxo-azetidine-1- Il-β-isopropylidene acetate. To a solution of Diphenylmethyl-o1- (1K, 5 $ -benzyl- (7-oxo-4-oxa-2,6-diazabiiiklo) -3,2, 0- (hept-2-ei-6-yl) -61- from isopropylideate (54 g) in dry propargyl alcohol (50 ml), boron trifluoride etherate (2 ml) was added. During the course of follow-up of the reaction by thin layer chromatography, an additional amount of ether and boric fluoride was added to the mixture (total 3.5 ml) After the disappearance of the starting material, the reaction mixture was drunk into a mixture of ethyl acetate (400 ml) and water (400 ml) with the addition of pieces of ice, stirred and neutralized with water. with sodium bicarbonate (2 g): The organic layer is separated and the aqueous layer is discharged with ethyl acetate, - (200 mp). The combined organic layer and the ethyl acetate wash solution are dried over sodium sulfate and evaporated dry, 50.5 g of product are obtained. The last section on a chromatographic column with Silica gel deactivated with 10% water (500 g) and blued with a mixture of benzene and ethyl acetate (19: 1 + 4: 1). The residue from the eluate is mixed with ether (50 mp) and the crystals are obtained as a precipitate. The crystals are separated by filtration and recrystallized from ethyl acetate to give the desired compound (20 g), m.p. 123.2-124.0С, 55.7 + 1.0 (chloroform, c 1.007). The structure of the obtained compound was confirmed by IR and NMR spectroscopy. Example 2 aj Diphenyl- 1-4 (R) - (3-bromopropargyloxy J-3 (L) -benzoyl: amino-2-oxo-azetidin-1-yl-o1-isopropenyl acetate. When heated Diphenylmethyl-A- (1K, 55) -3-phenyl-7-oxo-4-oxa-2, 6-diazabicyclo (3,2,0) -hept-2-en-B-yl-A- is dissolved isopropenylacetate (136 mg) in 3-bromopropargyl alcohol (61 µl). Zfirat trifluoride boron (2 µl) is added to the solution. The mixture is stirred for 45 mnu at room-1 temperature and then aged for two days. the selection as in example 1 and get the right, the compound (180 mg). The structure is confirmed by odes IR .i NMR spectroscopy b) Diphenylmethyl-C1-4 (R) -. (3-brompropargiloksi) -3 (R) -benzoilamino-2-oxo-azetidin-1-yl- -izopropilidenatsetat. The specified product (180 mg) was dissolved in methylene chloride (0.5 ml) and, in addition, triethylamine (41 µl) was added. The mixture is stirred at room temperature for 1 hour. The solvent is removed by evaporation to form a porous residue. Upon recrystallization from a mixture of pentene and ether, a powder of the desired compound (160 mg) is obtained. Structure confirmed by IR and NMR spectroscopy. Yield 90.8%. Examples 3-15. It is carried out analogously to example 1. The results are tabulated. The structure was confirmed by IR and NAN spectroscopy data. The invention method for producing tidinone derivatives of the general formulas 1a or 1b (CORj. OCHiRj оb "j CNj I methylene and methoxycarbon methylene, and 2 - acetoxy 1-methyltetrazol-5-yl-ti RJ - phenylmethoxy, diphenylme or tert-butyloxy. characterized in that the compound of the general formulas II a or IIb P 9 W. or ji-CH-C / 0 C I CH, SOVZ / where ftf and RJ have the above meanings, are reacted with an alcohol of the general formula Ml, where R has the above in the presence of boron trifluoride or trifluoromethysulfonic acid 0-40c followed by, if necessary, isomerization of the compound oOic & Attention Expertise 1. Corbett DE and Stoodley RJ Studies rebated to .us - J. Chen. Soc. Perkin Trans, 1974, Part I, 1, p. 185-188 (prototype).
    类似技术:
    公开号 | 公开日 | 专利标题
    US6069238A|2000-05-30|Spirocyclic C-glycosides
    DK162647B|1991-11-25|PROCEDURE FOR PREPARING PYRIDO-IMIDAZORIFAMYCINES
    WO1999035155A1|1999-07-15|Novel aromatic amides, preparation method and application as medicines
    Kuehne et al.1985|Studies in biomimetic alkaloid syntheses. 13. Total syntheses of racemic aspidofractine, pleiocarpine, pleiocarpinine, kopsinine, N-methylkopsanone, and kopsanone
    KR100426030B1|2004-04-03|Chirality conversion method in lactone sugar compounds
    SU869558A3|1981-09-30|Method of producing azetidinone derivatives
    AU607337B2|1991-02-28|Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
    US5132322A|1992-07-21|Etoposide analogues
    DK160829B|1991-04-22|Process for preparing pyridoimidazorifamycins
    KR100537595B1|2005-12-19|Process for preparing substance gm-95
    US4098993A|1978-07-04|Semi-synthetic 4-ureido-oleandomycin derivatives
    SU999977A3|1983-02-23|Process for producing 3,3-ethylene-4,5-seco-19-norandrost-9-ene-5,17-dion
    SU1318165A3|1987-06-15|Method for producing n-methylsulfonyl-1,2,8,8a-cycloprop |-benzo-|-dipyrrol-4|-on
    Pecunioso et al.1997|Synthesis and enantiomeric excess determination of |-1-|-6-|-cyclohexene
    Yamanaka et al.2003|A convenient method for the synthesis of α-imidostyrenes from styrenes and imides via diphenylstyrylsulfonium salts
    US4374774A|1983-02-22|Mitomycins
    Faigl et al.2003|Efficient methods for optional metalation of 1-| pyrroles in α or benzylic positions
    US5096905A|1992-03-17|Basic cleavage products of elaiophylin and elaiophylin derivatives and use thereof
    US5034380A|1991-07-23|Alkoxymethylidene epipodophyllotoxin glucosides
    Nakagawa et al.2000|Total synthesis of |-eudistomins with an oxathiazepine ring. Part 1. Formation of the oxathiazepine ring system
    US3875154A|1975-04-01|Certain 5-thia-1-azabicyclo{8 4.2.0{9 octenes
    KR102283391B1|2021-07-30|New synthetic method of decursin derivatives
    TANAKA et al.1983|Synthetic Studies on a Picrotoxane Sesquiterpene, Coriamyrtin. I. The Grignard Reaction of 5-| methyl-2, 5H-furanone with Isopropenylmagnesium Bromide and Stereochemistries of the Products
    KR100543172B1|2006-01-20|A Process for Preparing Terrein Compounds
    KR100226622B1|1999-10-15|Novel synthetic intermediate of muscone and the preparation thereof
    同族专利:
    公开号 | 公开日
    RO73274A|1981-11-24|
    YU29378A|1983-01-21|
    NZ186400A|1980-08-26|
    PH14953A|1982-02-02|
    IL53984D0|1978-04-30|
    BG31947A3|1982-04-15|
    FI780382A|1978-08-09|
    DK54678A|1978-08-09|
    PT67617A|1978-03-01|
    NO149352C|1984-04-04|
    GR70055B|1982-07-26|
    CH637637A5|1983-08-15|
    ES466741A1|1979-08-16|
    HU177509B|1981-10-28|
    CA1111856A|1981-11-03|
    JPS61335B2|1986-01-08|
    FR2379521A1|1978-09-01|
    NO149352B|1983-12-27|
    PL204672A1|1979-04-09|
    AR220700A1|1980-11-28|
    CS200539B2|1980-09-15|
    IE46389B1|1983-05-18|
    DE2805222A1|1978-08-10|
    AU515901B2|1981-05-07|
    AT357551B|1980-07-25|
    PL111962B1|1980-09-30|
    YU41306B|1987-02-28|
    US4233216A|1980-11-11|
    FI70571B|1986-06-06|
    NO780414L|1978-08-09|
    IE780221L|1978-08-08|
    PT67617B|1979-07-17|
    ZA78726B|1979-01-31|
    AU3304578A|1979-08-16|
    NL7801350A|1978-08-10|
    BE863700A|1978-05-29|
    FI70571C|1986-09-24|
    IL53984A|1983-05-15|
    DD134764A5|1979-03-21|
    SE7801352L|1978-08-09|
    ATA84378A|1979-12-15|
    SE437826B|1985-03-18|
    JPS5398951A|1978-08-29|
    GB1561704A|1980-02-27|
    FR2379521B1|1980-03-14|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    NL178005C|1972-11-06|1986-01-02|Merck & Co Inc|METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTIBACTERIAL ACTION, AND METHOD FOR PREPARING A CEPHALOSPORINE ANTIBIOTIC.|
    GB1505345A|1974-04-10|1978-03-30|Beecham Group Ltd|Cephalosporins|
    GB1552122A|1975-05-10|1979-09-05|Beecham Group Ltd|1-oxa-1-dethia-ceph-3-em-4-carboxylic acid derivatives preparation and compositions|
    US4143038A|1975-11-12|1979-03-06|Shionogi & Co., Ltd.|Cephalosporin analogues|
    US4070477A|1975-12-08|1978-01-24|Ciba-Geigy Corporation|2-Penem compounds|
    IT1058858B|1976-02-23|1982-05-10|Snam Progetti|5.6 DEHYDROPENICILLINS PROCESS FOR THEIR PREPARATION AND INTERMEDIATES OBTAINED IN THAT PROCESS|
    JPS607635B2|1976-04-27|1985-02-26|Shionogi & Co|US4443598A|1977-02-15|1984-04-17|Shionogi & Co., Ltd.|1-Oxadethiacepham compounds|
    GB1557552A|1977-02-15|1979-12-12|Shionogi & Co|1 oxadethiacepham compounds|
    US4504659A|1977-02-15|1985-03-12|Shionogi & Co., Ltd.|1-Oxadethiacepham compounds|
    JPS6228787B2|1979-04-03|1987-06-23|Shionogi & Co|
    US4243588A|1979-06-19|1981-01-06|Eli Lilly And Company|Process for novel oxazolinoazetidinones|
    JPH0355475B2|1982-08-24|1991-08-23|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    JP52013452A|JPS61335B2|1977-02-08|1977-02-08|
    [返回顶部]